deltatrials
Completed PHASE4 INTERVENTIONAL NCT00247338

The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients

Comparing With Traditional Nitrogen Calorie Parenteral Nutrition Support, the Impact of Low Calorie and Low Nitrogen Intake on the Clinical Outcome of Gastrointestinal Postoperative Patients, Multicentre Post-Marketing Clinical Study

Sponsor: Beijing 301 hospital

Conditions Gastrointestinal Neoplasms Postoperative Complications
Interventions low calorie, low nitrogen parenteral nutrition for patient with NRS score 3
Updated 6 times since 2017 Last updated: May 9, 2008 Started: Apr 30, 2005 Primary completion: Apr 30, 2006 Completion: May 31, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Gastrointestinal Neoplasms and Postoperative Complications and is currently completed. Beijing 301 hospital leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotCompleted~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Nov 2022 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing 301 hospital
  • Guangzhou S Y S Medical School hospital
  • Jie-Ping Wu Medical Foundation
  • Sino-Swed Pharmaceutical Corporation
  • Wuhan TongJi Hospital
Data source: Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations